Autoimmune mechanisms in cardiovascular diseases

Harefuah

Volumn 148, Issue 3, 2009, Pages 173-176

  Nussinovitch, Udi ^a   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Atherosclerosis; Autoimmunity; Chagas disease; Dilated cardiomyopathy; Heart failure

Indexed keywords

AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; HEART FAILURE; HUMAN; IMMUNOLOGY; MYOCARDITIS; REVIEW; RHEUMATIC FEVER;

AUTOIMMUNITY; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR DISEASES; CHAGAS DISEASE; HEART FAILURE; HUMANS; MYOCARDITIS; RHEUMATIC FEVER;

EID: 67649784017     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Rahamim-Cohen D & Shoenfeld Y, The mosaic of autoimmunity. A classical case of inhalation of a polyclonal activating factor in a genetically and hormonally susceptible patient leading to multiple autoimmune diseases. Isr Med Assoc J, 2001; 3: 381-2.
2. Doria A, Sarzi-Puttini P & Shoenfeld Y, Infections, rheumatism and autoimmunity: The conflicting relationship between humans and their environment. Autoimmun Rev, 2008.
3. Doria A & Sarzi-Puttini P, Heart, rheumatism and autoimmunity: an old intriguing link. Lupus, 2005; 14: 643-5.
4. Shoenfeld Y, Gilburd B, Abu-Shakra M & al, The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008. Isr Med Assoc J, 2008; 10: 3-7.
5. Shoenfeld Y, Zandman-Goddard G, Stojanovich L & al, The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr Med Assoc J, 2008; 10: 8-12.
6. Shoenfeld Y, Blank M, Abu-Shakra M & al, The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases-2008. Isr Med Assoc J, 2008; 10: 13-9.
7. Fu M, Autoimmunity and idiopathic dilated cardiomyopathy: where we stand? Autoimmunity, 2008; 41: 415-8.
8. Jessup M & Brozena S, Heart failure. N Engl J Med, 2003; 348: 2007-18.
9. Torre-Amione G, Immune activation in chronic heart failure. Am J Cardiol, 2005; 95: 3C-8C; discussion 38C-40C.
10. Frantz S, Bauersachs J & Kelly RA, Innate immunity and the heart. Curr Pharm Des, 2005; 11: 1279-90.
11. Nussinovitch U & Shoenfeld Y, Intravenous immunoglobulin - Indications and mechanisms in cardiovascular diseases. Autoimmun Rev, 2008; 7: 445-52.
12. Piepoli MF, Immune activation and inflammatory system in chronic heart failure: novel pathophysiological hypotheses generate new therapeutic options. Int J Clin Pract, 2007; 61: 536-8.
13. Cunha-Neto E, Bilate AM, Hyland KV & al, Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity, 2006; 39: 41-54.
14. Leon JS, Wang K & Engman DM, Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas' disease. J Immunol, 2003; 171: 4271-7.
15. Kierszenbaum F, Views on the autoimmunity hypothesis for Chagas disease pathogenesis. FEMS Immunol Med Microbiol, 2003; 37: 1-11.
16. Tarleton RL & Zhang L, Chagas disease etiology: autoimmunity or parasite persistence? Parasitol Today, 1999; 15: 94-9.
17. Engman DM & Leon JS, Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop, 2002; 81: 123-32.
18. Shoenfeld Y, Sherer Y & Harats D, Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol, 2001; 22: 293-5.
19. Doria A, Sherer Y, Meroni PL & al, Inflammation and accelerated atherosclerosis: basic mechanisms. Rheum Dis Clin North Am, 2005; 31: 355-62, viii.
20. de Leeuw K, Kallenberg C & Bijl M, Accelerated atherosclerosis in patients with systemic autoimmune diseases. Ann N Y Acad Sci, 2005; 1051: 362-71.
21. Sherer Y & Shoenfeld Y, Immunomodulation for treatment and prevention of atherosclerosis. Autoimmun Rev, 2002; 1: 21-7.
22. Shoenfeld Y, Gerli R, Doria A & al, Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation, 2005; 112: 3337-47.
23. George J, Afek A, Gilburd B & al, Autoimmunity in atherosclerosis: lessons from experimental models. Lupus, 2000; 9: 23-7.
24. Belizna CC, Richard V, Thuillez C & al, Insights into atherosclerosis therapy in antiphospholipid syndrome. Autoimmun Rev, 2007; 7: 46-51.
25. Li Y, Heuser JS, Cunningham LC & al, Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol, 2006; 177: 8234-40.
26. Li HS, Ligons DL & Rose NR, Genetic complexity of autoimmune myocarditis. Autoimmun Rev, 2008; 7: 168-73.
27. Krebs P, Kurrer MO, Kremer M & al, Molecular mapping of autoimmune B cell responses in experimental myocarditis. J Autoimmun, 2007; 28: 224-33.
28. Afanasyeva M, Georgakopoulos D & Rose NR, Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun Rev, 2004; 3: 476-86.
29. Eriksson U, Ricci R, Hunziker L & al, Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med, 2003; 9: 1484-90.
30. Carapetis JR, McDonald M & Wilson NJ, Acute rheumatic fever. Lancet, 2005; 366: 155-68.
31. Rheumatic fever and rheumatic heart disease: Report of a WHO expert consultation, Geneva, 29 October - 1 November 2001 World Health Organ Tech Rep Ser, 2004; 923.
32. Guilherme L, Kalil J & Cunningham M, Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity, 2006; 39:31-9.
33. Dec GW & Fuster V, Idiopathic dilated cardiomyopathy. N Engl J Med, 1994; 331: 1564-75.
34. st Edition,): New Jersey, USA:The Humana Press Inc, 2008, 367-373.
35. Caforio AL, Mahon NG, Baig MK & al, Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation, 2007; 115: 76-83.
36. Elliott P, Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy. Heart, 2000; 84: 106-12.
37. Mobini R, Maschke H & Waagstein F, New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy. Autoimmun Rev, 2004; 30:277-284.
38. Muller, II, Klingel K, Nikolaev VO & al, Immunoadsorption in a 40 year old man with dilated cardiomyopathy and underlying active myocarditis. Clin Res Cardiol, 2008.